Accuray Inc. Elects New Directors, Reports Executive Compensation

Ticker: ARAY · Form: 8-K · Filed: May 10, 2024 · CIK: 1138723

Sentiment: neutral

Topics: board-of-directors, executive-compensation, corporate-governance

Related Tickers: ACGY

TL;DR

Accuray adds two board members and updates exec pay details.

AI Summary

Accuray Incorporated announced on May 6, 2024, the election of two new directors, Dr. Suzanne L. Brundage and Mr. Kevin L. Johnson, to its Board of Directors. The company also reported on compensatory arrangements for its named executive officers. This filing is a current report under Section 13 or 15(d) of the Securities Exchange Act of 1934.

Why It Matters

The addition of new directors can signal strategic shifts or a response to governance considerations, while details on executive compensation are important for understanding management incentives and company spending.

Risk Assessment

Risk Level: low — This filing primarily concerns board appointments and executive compensation disclosures, which are routine corporate governance events.

Key Players & Entities

FAQ

Who were the new directors elected to Accuray's Board?

Dr. Suzanne L. Brundage and Mr. Kevin L. Johnson were elected as new directors to Accuray's Board of Directors.

What is the date of the earliest event reported in this 8-K filing?

The date of the earliest event reported is May 6, 2024.

What sections of the Securities Exchange Act of 1934 does this 8-K filing pertain to?

This 8-K filing pertains to Section 13 or 15(d) of the Securities Exchange Act of 1934.

What is the principal executive office address for Accuray Incorporated?

The address of Accuray Incorporated's Principal Executive Offices is 1240 Deming Way, Madison, Wisconsin 53717-1954.

What is the SIC code for Accuray Incorporated?

The Standard Industrial Classification (SIC) code for Accuray Incorporated is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.

Filing Stats: 723 words · 3 min read · ~2 pages · Grade level 12.3 · Accepted 2024-05-10 16:01:11

Key Financial Figures

Filing Documents

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ACCURAY INCORPORATED Dated: May 10, 2024 By: /s/ Jesse Chew Jesse Chew Senior Vice President, Chief Legal Officer & Corporate Secretary 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing